GETTING MY RAW MATERIALS TO WORK

“The current situation has exposed some structural weaknesses while in the EU’s medicines source chain in addition to a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides claimed. She proposed that supply chain issues be addressed within an EU pharmaceutical method envisioned being launch